Información bibliográfica
GuíaWHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis in eastern Africa and South-East Asia
Año de publicación2026
Institución emisoraWorld Health Organization
Recomendación
Nueva
Management of visceral leishmaniasis (VL) patients in eastern Africa. Use of liposomal amphotericin B (LAmB) is suggested in patients in whom paromomycin plus miltefosine and/or pentavalent antimonial plus paromomycin is excluded
Recomendado a favor
Condicional
Certeza de la evidencia
Muy baja